Edition:
United Kingdom

Zealand Pharma A/S (ZEAL.OQ)

ZEAL.OQ on NASDAQ Stock Exchange Global Select Market

14.06USD
16 Oct 2018
Change (% chg)

-- (--)
Prev Close
$14.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,694
52-wk High
$19.12
52-wk Low
$12.01

Chart for

About

Zealand Pharma A/S is a Denmark-based biopharmaceutical company engaged in the discovery, development and commercialization of peptide-based medicines. The Company's pipeline comprises two implementation areas: Cardio-metabolic diseases and Other indications. The Cardio-metabolic diseases area includes medicines for diabetes and... (more)

Overall

Beta: 0.84
Market Cap(Mil.): kr.3,751.36
Shares Outstanding(Mil.): 30.75
Dividend: --
Yield (%): --

Financials

  ZEAL.OQ Industry Sector
P/E (TTM): -- 85.92 33.73
EPS (TTM): -4.08 -- --
ROI: -26.95 0.63 14.31
ROE: -67.92 1.68 16.04

BRIEF-Zealand Q1 Net Sales Of Soliqua 100/33 And Lyxumia/Adlyxin At EUR 14.5 Mln

* REG-ZEALAND ANNOUNCES NET SALES OF SOLIQUA® 100/33 AND LYXUMIA®/ADLYXIN® FOR THE FIRST QUARTER OF 2018

27 Apr 2018

BRIEF-Zealand Announces Successful End-Of-Phase 2 Meeting With FDA On Glepaglutide For Short Bowel Syndrome

* ZEALAND ANNOUNCES SUCCESSFUL END-OF-PHASE 2 MEETING WITH FDA ON GLEPAGLUTIDE FOR SHORT BOWEL SYNDROME

26 Apr 2018

Earnings vs. Estimates